loading
Schlusskurs vom Vortag:
$2.06
Offen:
$2.04
24-Stunden-Volumen:
35,786
Relative Volume:
0.15
Marktkapitalisierung:
$7.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.47M
KGV:
-4.06
EPS:
-0.5
Netto-Cashflow:
$-13.51M
1W Leistung:
-8.56%
1M Leistung:
+12.78%
6M Leistung:
+14.04%
1J Leistung:
-65.02%
1-Tages-Spanne:
Value
$2.02
$2.07
1-Wochen-Bereich:
Value
$2.02
$2.2899
52-Wochen-Spanne:
Value
$1.30
$6.972

Nls Pharmaceutics Ltd Stock (NLSP) Company Profile

Name
Firmenname
Nls Pharmaceutics Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
NLSP's Discussions on Twitter

Vergleichen Sie NLSP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NLSP
Nls Pharmaceutics Ltd
2.03 10.11M 0 -15.47M -13.51M -0.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.62 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.80 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.43 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
722.01 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.26 36.53B 3.81B -644.79M -669.77M -6.24

Nls Pharmaceutics Ltd Aktie (NLSP) Neueste Nachrichten

pulisher
Sep 03, 2025

Statistical indicators supporting NLS Pharmaceutics AG Equity Warrant’s strength2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Predicting NLS Pharmaceutics AG Equity Warrant trend using moving averagesQuarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Analyzing drawdowns of NLS Pharmaceutics AG Equity Warrant with statistical toolsM&A Rumor & AI Forecasted Stock Moves - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using RSI to spot recovery in NLS Pharmaceutics AGPrice Action & AI Driven Stock Movement Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time pattern detection on NLS Pharmaceutics AG stock2025 Risk Factors & AI Enhanced Trade Execution Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Signal strength of NLS Pharmaceutics AG Equity Warrant stock in tech scanners - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to use Fibonacci retracement on NLS Pharmaceutics AG Equity WarrantJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

When is the best time to exit NLS Pharmaceutics AG Equity WarrantJuly 2025 Breakouts & Expert-Curated Trade Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tick level data insight on NLS Pharmaceutics AG volatilityFed Meeting & Proven Capital Preservation Methods - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Short interest data insights for NLS Pharmaceutics AGQuarterly Profit Summary & Weekly High Return Forecasts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Price action breakdown for NLS Pharmaceutics AG Equity WarrantWeekly Volume Report & Expert Approved Momentum Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Key metrics from NLS Pharmaceutics AG Equity Warrant’s quarterly dataTrade Exit Report & Technical Entry and Exit Alerts - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Using Bollinger Bands to evaluate NLS Pharmaceutics AG Equity WarrantTrade Signal Summary & Weekly High Return Stock Forecasts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

NLS Pharmaceutics AG Equity Warrant stock momentum explainedJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Price momentum metrics for NLS Pharmaceutics AG Equity Warrant explainedJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is NLS Pharmaceutics AG stock entering bullish territoryJuly 2025 Recap & AI Based Trade Execution Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Visual analytics tools that track NLS Pharmaceutics AG Equity Warrant performanceTrade Analysis Summary & Safe Capital Growth Tips - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

NLS Pharmaceutics AG Equity Warrant’s volatility index tracking explainedJuly 2025 Setups & Fast Entry High Yield Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Watch for Trend Continuation in NLS Pharmaceutics AG Next Week2025 Market WrapUp & Safe Entry Zone Identification - beatles.ru

Aug 31, 2025
pulisher
Aug 31, 2025

Using R and stats models for NLS Pharmaceutics AG forecastingWall Street Watch & Free Community Supported Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Ichimoku Cloud for NLS Pharmaceutics AG technicals2025 Institutional Moves & AI Powered Buy and Sell Recommendations - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Top chart patterns to watch in NLS Pharmaceutics AG Equity WarrantTrade Risk Assessment & Low Volatility Stock Suggestions - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is NLS Pharmaceutics AG Equity Warrant stock entering bullish territory2025 Year in Review & Real-Time Stock Price Movement Reports - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Comparing NLS Pharmaceutics AG Equity Warrant in custom built stock radarsPortfolio Value Report & Real-Time Market Trend Scan - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Building trade automation scripts for NLS Pharmaceutics AG Equity WarrantMarket Growth Summary & Breakout Confirmation Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

NLS Pharmaceutics Extends Merger Deadline with Kadimastem to October 31, 2025. - AInvest

Aug 30, 2025
pulisher
Aug 30, 2025

NLS Pharmaceutics Extends Merger Agreement with Kadimastem - TipRanks

Aug 30, 2025
pulisher
Aug 29, 2025

Detecting support and resistance levels for NLS Pharmaceutics AGInsider Selling & Technical Entry and Exit Tips - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Is NLS Pharmaceutics AG Equity Warrant a candidate for recovery playTrade Exit Summary & Safe Capital Growth Tips - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Published on: 2025-08-29 16:48:48 - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Best data tools to analyze NLS Pharmaceutics AG stockTrade Analysis Report & Daily Volume Surge Signals - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Is this a good reentry point in NLS Pharmaceutics AG Equity WarrantWeekly Risk Report & Trade Opportunity Analysis Reports - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Risk vs reward if holding onto NLS Pharmaceutics AGQuarterly Market Summary & Expert Approved Momentum Ideas - Newser

Aug 29, 2025

Finanzdaten der Nls Pharmaceutics Ltd-Aktie (NLSP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$86.96
price up icon 1.14%
$27.08
price up icon 4.60%
$23.52
price down icon 1.34%
$100.42
price down icon 0.20%
$143.50
price down icon 1.24%
biotechnology ONC
$336.26
price up icon 1.27%
Kapitalisierung:     |  Volumen (24h):